Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neurokinin 3 receptor (NK3R) is a class A GPCR that is primarily activated by the endogenous neuropeptide neurokinin B (NKB). It plays a crucial role in thermoregulation, particularly in mediating menopausal hot flashes through its action on hypothalamic KNDy neurons. NK3R is also involved in regulating reproductive hormone secretion via GnRH modulation. Selective NK3R antagonists, such as fezolinetant, are approved for the treatment of menopausal vasomotor symptoms, while other investigational agents are being explored for broader therapeutic applications, including oncology.
Selective antagonism of the neurokinin 3 receptor, leading to decreased activity of KNDy neurons in the hypothalamus and reduced hot flash frequency.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurokinin 3 Receptor (NK3R).